1 Min Read
FRANKFURT, June 24 (Reuters) - Bayer AG : * Says new data affirm Xarelto effectiveness as single-drug therapy for the
treatment of pulmonary embolism and deep vein thrombosis
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.